Filter posts

U-T San Diego Commentary: Lack of Preparedness to Ebola Is Symptom of Larger Disease

Last week, the U-T San Diego published an op-ed by Betrand Liang, CEO of Pfenex …

BIO Presents at 2014 Biological Weapons Convention Meeting of Experts

Last week marked the annual Biological Weapons Convention (BWC) Meeting of Experts in Geneva. The …

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, …

BIO Calls for Adequate Funding of Vaccine and Biodefense Programs

It’s budget time here in Washington, with appropriators in the House and Senate working overtime …

Act Now to Protect Public Health and Prepare for the Upcoming Flu Season

As many as 49,000 people die from the flu annually, depending on the season, and …

Renewing the Project BioShield Act: What Has It Bought and Wrought?

In the next several months, the U.S. Government will decide whether to continue the funding …

CDC Addresses Flu Vaccine Shortage

Did you get your flu shot this year? With 48 states reporting widespread influenza activity, …

The Future of Biodefense: Will Public-Private Partnerships Continue?

Ten years ago, in the wake of the 2001 anthrax attacks, the U.S. government set …

#BIF2012 Company Snapshot: Chimerix

Our next Company Snapshot for next week’s BIO Investor Forum is Chimerix. They will be …

Importance of Reauthorizing Pandemic All-Hazards Preparedness Act

Senator Robert P. Casey, Jr. (D-PA) joined with BIO and The Center for Biosecurity of …